[Atypical hemolytic and uremic syndrome in Algeria: diagnostic difficulties and therapeutic constraints].

Atypical Hemolytic Uremic Syndrome (aHUS) is a systemic disease due to dysregulation of the alternate complement pathway, mortality is estimated at 10% and more than 50% of patients progress to end-stage renal disease. The aim of this study was to summarize the clinical data and biological results as well as the evolution and management of patients with aHUS seen over a period of four years in one specialized department in Algeria. Our study was observational and longitudinal.

Relationship of metabolic syndrome and its components with thyroid dysfunction in Algerian patients.

Aims: The aim of this study is to evaluate the prevalence of the metabolic syndrome and its compounds in subjects with different thyroid status.

Materials And Methods: A prospective cross-sectional study was conducted in the internal medicine department at El Okbi Hospital of Guelma (East of Algeria) from January 2014 to September 2015. Eighty six patients attending the specialist consultation for suspected thyroid disorders were included in the study.

3-{[(E)-(2-Hydroxynaphthalen-1-yl)methylidene]amino}pyridinium per-chlorate.

In the title Schiff base salt, C16H13N2O(+)·ClO4 (-), the pyridine ring and the naphthalene ring system are approximately co-planar [making a dihedral angle of 6.05 (12)°] and an intra-molecular O-H⋯N hydrogen bond occurs between the hydroxyl and imino groups. In the crystal, the cations and anions are linked by N-H⋯O and weak C-H⋯O hydrogen bonds, forming the supra-molecular layers parallel to (100).

8-Hy-droxy-quinolin-1-ium hydrogen sulfate monohydrate.

In the crystal structure of the title salt hydrate, C9H8NO(+)·HSO4 (-)·H2O, the quinoline N-H atoms are hydrogen bonded to the bis-ulfate anions. The bis-ulfate anions and water mol-ecules are linked together by O-H⋯O hydrogen-bonding inter-actions. The cations and anions form separate layers alternating along the c axis, which are linked by N-H⋯O and O-H⋯O hydrogen bonds into a two-dimensional network parallel to (100).

Di-μ-chlorido-bis-[(2-amino-benzamide-κ(2) N (2),O)chlorido-copper(II)].

The title compound, [Cu2Cl4(C7H8N2O)2], crystallizes as discrete [CuLCl2]2 (L = 2-amino-benzamide) dimers with inversion symmetry. Each Cu(II) ion is five-coordinated and is bound to two bridging chloride ligands, a terminal chloride ligand and a bidentate 2-amino-benzamide ligand. The crystal structure exhibits alternating layers parallel to (010) along the b-axis direction.